Navigation Links
Sanford Wittels & Heisler Files $100 Million Gender Discrimination Class Action In Southern District Of New York
Date:7/5/2012

action is the only recourse women have to address these grievous wrongs and to restore female employees' rights."

Moreover, the plaintiffs were paid less than similarly situated male employees at Forest, despite their exemplary performance, and were denied bonuses, promotions, and other employment incentives as a result of their gender and their taking maternity leave.

"Forest either does not have or does not follow policies that reduce or eliminate disparate impact on women and gender bias," said Mr. Sanford.  "Instead, the company permits the gender stereotypes of Forest's predominately male managerial and supervisory staff to influence the company's personnel decisions.  These practices are clearly illegal and must be stopped before other female employees' lives and livelihoods are affected."

Forest Laboratories' (NYSE: FRX) is a global company that develops and markets prescription and non-prescription pharmaceutical products across the United States. The company's revenue in the twelve months that ended March 31, 2011 was $4.4 billion. Forest Pharmaceuticals is one of the 15 largest U.S. pharmaceutical companies and has more than 5,000 employees.

Today's Complaint is not the first time women have filed Complaints alleging gender and pregnancy discrimination at Forest. In the past year, Forest has been named as a defendant in gender and pregnancy discrimination cases filed in Alabama and Ohio.

Today's filing seeks certification of a class as the most efficient and economical means of addressing the questions of law common to the plaintiffs' claims of a systematic pattern and practice of gender discrimination by Forest against its female employees. The Complaint also seeks injunctive relief that includes a restructuring of many of Forest's personnel policies and procedures so that female employees can enjoy the same conditions of employme
'/>"/>

SOURCE Sanford Wittels & Heisler, LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
4. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
5. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
6. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
9. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
10. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
11. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... NEWTON, Mass. and JERUSALEM ... privately-held biopharma company developing octreotide capsules, its lead product ... of a $70 million Series E financing round. Participants ... and Sofinnova Ventures, and an undisclosed blue chip public ... F2 Capital, 7 Med Health Ventures, Abingworth and ARCH ...
(Date:2/26/2015)... , Feb. 27, 2015  Finesse expands office in ... Solutions announced the expansion of its operations in ... for mid-March and access for customers is expected shortly ... and located adjacent to the current office, the new ... engineering team and allow Finesse to bring on more ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3New Finesse Office in United Kingdom 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... published in the American Journal of Nephrology -, ... announced that its Phase III data on VAPRISOL was ... Nephrology. In this study,VAPRISOL showed a significant increase in ... life-threatening condition that,occurs when the body,s sodium level falls ...
... Cancer patients at Beaumont,Hospitals are the first in the ... therapy that is painless, faster, more accurate and precise,than ... patented the new,technology, Omnibeam(R). The $3.3-million machine is manufactured ... first patient,was treated on Sept. 10. The painless ...
Cached Medicine Technology:Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 2Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 3Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 4Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia 5Beaumont Patients 1st to get Next Generation of Radiation Treatment 2
(Date:2/27/2015)... (PRWEB) February 27, 2015 According to ... in the China Dental Industry in 2013 rose by ... the total amount of revenue generated by the industry ... that was registered by the industry in 2013. ... The report has identified the oral industry as a ...
(Date:2/27/2015)... 2015 Several studies showing the promise ... have made headline news recently. However, all these studies ... in this month’s STEM CELLS Translational Medicine shows that ... children with congenital heart diseases that can lead to ... at the Mayo Clinic in Rochester, Minn., looked at ...
(Date:2/27/2015)... 2015 Ticket Down announces that Ed ... summer months of 2015. Tickets for his tour have ... at a record pace. , Ed Sheeran 2015 ... Erwin Center, Wednesday, May 6, 2015 , 5/7/15, Ed Sheeran ... May 7, 2015 , 5/9/15, Ed Sheeran Tickets, Tulsa, OK ...
(Date:2/27/2015)... 27, 2015 Burien Nursing and ... Health Care, Inc. with the Facility of the ... four key areas: Outstanding quality of care / satisfaction, ... Lynda Baldwin was invited to attend the awards banquet ... “I am delighted to receive this award on behalf ...
(Date:2/27/2015)... RDI-Engineering will be hosting an educational ... on March 14, at Moreno Valley College. The station ... to use engineering software and tools, and a few ... Moreno Valley College’s Upward Bound Math and Science (UBMS) ... hopes to encourage students to seek educational and career ...
Breaking Medicine News(10 mins):Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:Study Shows Stem Cells Have Potential to Help Kids’ Hearts, Too 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 2Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 3Health News:Ed Sheeran Tickets at the Hollywood Bowl, Verizon Theatre, The Mann Center, Darlings Waterfront Pavilion, Moda Center, BOK Center, Consol Energy & Red Rocks Now On Sale 4Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 2Health News:Burien Nursing and Rehabilitation Center Receives Top Honors with Facility of the Year Award 3Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2
... , NASHVILLE, Tenn. , Jan. 26 ... announced that on Monday evening, February 22, 2010 , after ... of 2009.   , On February 23, 2010 , at ... a conference call to discuss earnings results, quarterly activities, general operations ...
... , , OAKLAND, Calif. , ... union election results for Kaiser Permanente nurses, psych-social ... Trossman , communications director of the Service Employees ... statement: , "While today,s election results are disappointing, ...
... Jan. 26 Yesterday, Randall Terry , who is regrettably ... news release, "We are not coming to condone or condemn Scott ... figure John Brown . , The Advisory Board of Operation Rescue ... violence. , "The Board of Operation Rescue wants to make it clear ...
... CLEVELAND , Jan. 26 The Cleveland ... will host a panel discussion Feb. 18 addressing ... http://www.newscom.com/cgi-bin/prnh/20070517/IABCLOGO ) , Health care communication leaders from ... care reform, public option, social media and more are impacting ...
... , BALTIMORE , Jan. 26 Lutheran World ... has arrived safely. , "Our partners at Church World Service ... immediately to the people who need it," says Trevor Knoblich ... jointly by LWR and CWS, contained health kits and layettes from ...
... , COLUMBUS, Ohio , Jan. 26 ... of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 30mL and 120mL ... and Drug Administration. This product is indicated for the relief of ... opioid analgesic is appropriate. , Roxane Laboratories, Inc. Morphine Sulfate Oral ...
Cached Medicine News:Health News:Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call 2Health News:SEIU-UHW Statement on Kaiser Union Election in Southern California 2Health News:Operation Rescue's Advisory Board Issues Statement on Mr. Terry's Extremism 2Health News:IABC Cleveland Presents 'The Changing Face of Health Care Communications' at Feb. 18 Luncheon 2Health News:LWR Health Kits, Layettes Arrive in Haiti as Relief Efforts Ramp Up 2Health News:LWR Health Kits, Layettes Arrive in Haiti as Relief Efforts Ramp Up 3Health News:Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 2Health News:Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL) 3
Flexible rake retractor, 3 blunt prongs....
Rees bayonet forceps, standard, 5-1/2", TC....
... Implants, designed to accept rigid ... with an excellent reconstructive option ... floor blowout defects. Each design ... of one or more rigid ...
... Medpor Midface Rim is designed ... concavities of the midface, including ... malar. When positioned in the ... Medpor Midface Rim implant aids ...
Medicine Products: